Ben Franklin bill with surgeon mask The Partnership for America’s Health Care Future spent a combined $143 million lobbying in 2018, and it’s just getting started. (Image: Shutterstock)

If health insurers have their way, Medicare for All will be a nonstarter. And they’ve got the lobbying battle lines drawn to prove it—with pharmaceutical companies on their side.

The Hartford Courant reports that insurers, which dominate the state economy in Connecticut, have teamed up not just with the pharmaceutical industry but also with the American Medical Association and the Federation of American Hospitals in a pitched-battle effort to keep “Medicare for All proposals and other Democratic plans to alter the nation’s health care” from becoming reality.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.